These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36205826)

  • 1. Significance of abnormal blood coagulation in patients with chronic myelomonocytic leukemia.
    Weinfurtner C; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):9-14. PubMed ID: 36205826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of reduced renal function in patients with chronic myelomonocytic leukemia.
    Heschl J; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):3-8. PubMed ID: 36282402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia.
    Zack MT; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):21-26. PubMed ID: 36445600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
    Geissler K; Jäger E; Barna A; Graf T; Graf E; Öhler L; Hoermann G; Valent P
    Eur J Haematol; 2021 May; 106(5):627-633. PubMed ID: 33432601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance].
    Xiao FF; Hu KX; Guo M; Qiao JH; Sun QY; Ai HS; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):300-4. PubMed ID: 23628020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Karyotypic analysis and prognosis for 41 patients with chronic myelomonocytic leukemia].
    Lu Y; Yu MX; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):134-7. PubMed ID: 23568720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of C-reactive protein in patients with chronic myelomonocytic leukemia.
    Liang-Fonseca J; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):15-20. PubMed ID: 36441359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia.
    Lackner D; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):27-33. PubMed ID: 36414855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
    Onida F; Kantarjian HM; Smith TL; Ball G; Keating MJ; Estey EH; Glassman AB; Albitar M; Kwari MI; Beran M
    Blood; 2002 Feb; 99(3):840-9. PubMed ID: 11806985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
    Kim HY; Lee KO; Park S; Jang JH; Jung CW; Kim SH; Kim HJ
    Ann Lab Med; 2018 Nov; 38(6):495-502. PubMed ID: 30027691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.
    González JS; Perusini MA; Basquiera AL; Alfonso G; Fantl D; Lima WM; Nucifora E; Lazzarino C; Novoa V; de Andrade Silva MC; Larripa IB; Rocha V; Arbelbide J; Velloso EDRP; Belli CB
    Ann Hematol; 2021 Jun; 100(6):1439-1449. PubMed ID: 33932168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.
    Geissler K; Jäger E; Barna A; Gurbisz M; Marschon R; Graf T; Graf E; Borjan B; Jilch R; Geissler C; Hoermann G; Esterbauer H; Schwarzinger I; Nösslinger T; Pfeilstöcker M; Tüchler H; Reisner R; Sliwa T; Keil F; Bettelheim P; Machherndl-Spandl S; Doleschal B; Zach O; Weltermann A; Heibl S; Thaler J; Zebisch A; Sill H; Stauder R; Webersinke G; Petzer A; Kusec R; Ulsperger E; Schneeweiss B; Berger J; Öhler L; Germing U; Sperr WR; Knöbl P; Jäger U; Valent P
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):410-418. PubMed ID: 31321531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.
    Nösslinger T; Reisner R; Grüner H; Tüchler H; Nowotny H; Pittermann E; Pfeilstöcker M
    Leuk Res; 2001 Sep; 25(9):741-7. PubMed ID: 11489467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems in the classification of CMML--dysplastic versus proliferative type.
    Germing U; Gattermann N; Minning H; Heyll A; Aul C
    Leuk Res; 1998 Oct; 22(10):871-8. PubMed ID: 9766745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic risk stratification in chronic myelomonocytic leukemia.
    Such E; Cervera J; Costa D; Solé F; Vallespí T; Luño E; Collado R; Calasanz MJ; Hernández-Rivas JM; Cigudosa JC; Nomdedeu B; Mallo M; Carbonell F; Bueno J; Ardanaz MT; Ramos F; Tormo M; Sancho-Tello R; del Cañizo C; Gómez V; Marco V; Xicoy B; Bonanad S; Pedro C; Bernal T; Sanz GF
    Haematologica; 2011 Mar; 96(3):375-83. PubMed ID: 21109693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune thrombocytopenia in chronic myelomonocytic leukemia.
    Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
    Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.